Myriad Genetics, Inc. (NASDAQ:MYGN) CEO Paul J. Diaz Sells 57,844 Shares of Stock
Myriad Genetics, Inc. (NASDAQ:MYGN – Get Free Report) CEO Paul J. Diaz sold 57,844 shares of the business’s stock in a transaction dated Monday, May 13th. The shares were sold at an average price of $25.13, for a total transaction of $1,453,619.72. Following the transaction, the chief executive officer now directly owns 1,236,166 shares of […]